Switching from Sertraline to Bupropion in an 87-Year-Old Nursing Home Resident
In this 87-year-old nursing home resident with treatment-resistant depression and prolonged grief, switching from sertraline (Zoloft) to bupropion (Wellbutrin) offers no proven efficacy advantage but may reduce specific adverse effects—particularly sexual dysfunction, gastrointestinal symptoms, and somnolence—though this comes with increased seizure risk and requires careful cardiovascular monitoring in this age group.
Key Evidence on Efficacy
The evidence does not support superior antidepressant efficacy when switching between second-generation antidepressants. Second-generation antidepressants show no clinically significant differences in efficacy, effectiveness, or quality of life for treating major depressive disorder 1. This applies equally across age groups, including the very elderly (>80 years) 1. When patients fail to respond to one SSRI, switching to bupropion versus another SSRI shows similar response and remission rates 2.
For nursing home residents specifically, SSRIs are recommended as first-line treatment, with no evidence supporting routine switching to other classes for improved efficacy 3.
Potential Benefits of Switching to Bupropion
1. Reduced Sexual Dysfunction
Bupropion has significantly lower rates of sexual adverse events compared to sertraline 1. While sexual dysfunction may seem less relevant in an 87-year-old nursing home resident, it can still impact quality of life and relationship satisfaction.
2. Fewer Gastrointestinal Side Effects
Sertraline causes higher rates of diarrhea than bupropion 1. Bupropion is associated with less nausea, diarrhea, and somnolence compared to SSRIs 4. In a frail elderly patient, reducing GI symptoms and sedation can meaningfully improve functional status and quality of life.
3. Less Somnolence
Bupropion causes less somnolence than SSRIs 4. In nursing home residents where excessive sedation increases fall risk and worsens cognitive function, this represents a tangible benefit.
4. No Weight Gain
Unlike some antidepressants (particularly mirtazapine and paroxetine), bupropion does not cause weight gain 1. This may be relevant if the patient has experienced weight changes on sertraline.
Critical Risks and Contraindications in This Population
Seizure Risk
Bupropion carries an increased risk of seizures 1, 5. This is particularly concerning in elderly patients with:
- History of stroke or TIA
- Dementia (especially vascular dementia)
- Concurrent medications that lower seizure threshold
- Alcohol use or benzodiazepine withdrawal
The FDA label explicitly states bupropion is contraindicated in patients with brain metastases or seizure disorders 5.
Cardiovascular Concerns
In elderly patients, bupropion can cause:
- Hypertension: Mean systolic BP increase of 1.3 mmHg, with 2% developing clinically significant hypertension requiring discontinuation 5
- Exacerbation of pre-existing hypertension 5
- No controlled safety data in patients with recent MI or unstable cardiac disease 5
Blood pressure monitoring is essential when initiating bupropion in this age group 5.
Neuropsychiatric Adverse Events
Bupropion can cause delusions, hallucinations, psychosis, confusion, and paranoia 5. In an elderly patient with potential underlying cognitive impairment, these risks are amplified.
Practical Algorithm for Decision-Making
Screen for Contraindications First:
- History of seizures, stroke, or TIA → Do not switch to bupropion
- Uncontrolled hypertension → Do not switch to bupropion
- Concurrent alcohol use or benzodiazepine use → High risk; avoid bupropion
- Dementia with behavioral symptoms → Consider alternative (e.g., mirtazapine)
If No Contraindications, Consider Switch If:
- Prominent somnolence limiting function
- Significant GI side effects (diarrhea, nausea)
- Sexual dysfunction affecting quality of life
- Patient preference after discussing risks/benefits
Dosing in Elderly:
Start bupropion XL 150 mg daily in the morning. Do not exceed 150 mg daily initially in elderly patients 5. If tolerated after 3-4 weeks and response is inadequate, may increase to 300 mg daily with close monitoring.
Monitoring Requirements:
- Baseline and weekly blood pressure for first month
- Assess for agitation, confusion, or behavioral changes at each visit
- Evaluate response at 6 and 12 weeks 3
Alternative Strategies to Consider First
Before switching antidepressants, ensure adequate trial duration (6-8 weeks at therapeutic dose) 1. If sertraline was underdosed or trial duration insufficient, optimize current therapy first.
Augmentation strategies may be superior to switching 2, 6. Adding bupropion to sertraline shows effectiveness in treatment-resistant depression 7, 8, though this increases pill burden and drug interaction risk.
For elderly nursing home residents with depression and grief, psychotherapy (particularly cognitive therapy) shows similar efficacy to medication switches 2, 6 and may be preferable given lower adverse event risk.
Common Pitfalls to Avoid
Assuming all antidepressants are equally safe in the elderly: Bupropion's seizure and cardiovascular risks make it less suitable than SSRIs for many elderly patients 9, 10
Overlooking medication interactions: Bupropion is metabolized by CYP2B6 and inhibits CYP2D6; review all concurrent medications 5
Inadequate monitoring: Blood pressure and neuropsychiatric symptoms require systematic tracking 5
Ignoring non-pharmacologic interventions: In prolonged grief, psychotherapy and social interventions may be more appropriate than medication switches 3
Bottom Line
The primary rationale for switching to bupropion is tolerability, not efficacy. In an 87-year-old nursing home resident, the risks (seizures, hypertension, neuropsychiatric effects) often outweigh the benefits (reduced sexual dysfunction, less sedation) unless specific tolerability issues with sertraline are limiting function or quality of life. Consider augmentation with psychotherapy or optimizing the current SSRI dose before switching 3, 1.